Black Diamond Therapeutics, Inc (BDTX) Financials

BDTX Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 158.6 million 41.8 million
2023-09-30 172.4 million 38.1 million
2023-06-30 119.9 million 37.7 million
2023-03-31 135.6 million 37.4 million

BDTX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -14.0 million 1.5 million
2023-09-30 -18.4 million 2.8 million
2023-06-30 -14.4 million 2.6 million
2023-03-31 -20.0 million 2.7 million

BDTX Net Income

No data available :(

BDTX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 131.4 million - 25.3 million
2023-09-30 144.3 million - 26.0 million
2023-06-30 89.5 million - 26.8 million
2023-03-31 103.4 million - 27.5 million

BDTX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 51.6 million
2023-09-30 50.9 million
2023-06-30 36.5 million
2023-03-31 36.5 million

BDTX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 15.2 million 5.6 million -
2023-09-30 33000 16.2 million 7.9 million -
2023-06-30 34000 13.2 million 6.9 million -
2023-03-31 - 14.8 million 6.8 million -

BDTX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 86000
2023-09-30 - 823000
2023-06-30 - 812000
2023-03-31 - 812000

BDTX

Price: $6.96

52 week price:
1.43
6.96

Earnings Per Share: -1.88 USD

P/E Ratio: -2.51

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 81500

Market Capitalization: 278.2 million

Links: